MedPath

To evaluate the efficacy of lajjalu taila in uterine prolapse

Not Applicable
Conditions
Health Condition 1: N812- Incomplete uterovaginal prolapse
Registration Number
CTRI/2023/01/048677
Lead Sponsor
Shri BMK Ayurveda Mahavidyalaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

First Degree Uterine Prolapse with Subjective Symptoms

Second Degree Uterine Prolapse with Subjective Symptoms

First Degree Uterine Prolapse with Urethrocele or Rectocele or Cystocele

Second Degree Uterine Prolapse with Urethrocele or Rectocele or Cystocele

Urethrocele or Rectocele or cystocele

Exclusion Criteria

Third degree uterine prolapse with or without decubitus ulcer

Vault prolapses

Cysto-urethrocele

Recent history of exposure to cytotoxic drugs or pelvic radiation therapy

K/C/O Sexually transmitted diseases

Subjects with known cases of congenital anomalies and carcinoma of reproductive tract

Patients with other major systematic disorders which interfere with the treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There will be significant effect of Lajjalu taila in Uterine ProlapseTimepoint: 0th, 5th, 35th and 70th Days
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath